Clinic
Forme Medical Center, INC.
Forme Medical Center, INC. was paid $3.23M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 20% of everything it billed.
33Billing provider infoFORME MEDICAL CENTER, INC.
WHITE PLAINS, NY 10601
WHITE PLAINS, NY 10601
33aNPI1083755920assigned 02/12/2007
33bProvider typeRehabilitation Clinic/Center
28Total paid$3.23M
24GClaims57,152
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rehabilitation Clinic/Center providers in New York
Rank by total paid#5 of 15
Median peer was paid$968K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,523 | $336K | |
| 2019 | 1,346 | $204K | |
| 2020 | 5,540 | $314K | |
| 2021 | 21,901 | $955K | |
| 2022 | 19,128 | $855K | |
| 2023 | 4,906 | $346K | |
| 2024incomplete | 2,808 | $221K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 20% | 8,863 | 6,722 | $635K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 6,503 | 5,612 | $573K |
| S9083 | Global fee urgent care centers | 14% | 1,183 | 1,094 | $467K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 4,805 | 4,227 | $409K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 12% | 5,008 | 4,722 | $395K |
| 99401 | 7.9% | 8,597 | 7,161 | $256K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.5% | 11,425 | 9,365 | $144K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.7% | 4,472 | 3,949 | $121K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.3% | 730 | 715 | $75K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 1,547 | 1,437 | $52K |
| 99201 | <1% | 235 | 222 | $18K | |
| 36410 | <1% | 783 | 742 | $15K |
28 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 142 | $14K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 119 | $12K |
| 93923 | <1% | 81 | $9K | |
| 90674 | <1% | 342 | $8K | |
| 90756 | <1% | 241 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 834 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 40 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 230 | $2K |
| 97799 | <1% | 40 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 83 | $1K |
| 0002A | <1% | 42 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 48 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 87 | $1K |
| 90686 | <1% | 46 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 130 | $592.75 |
| 93000 | <1% | 105 | $396.19 | |
| 0001A | <1% | 42 | $358.92 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 25 | $157.76 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 20 | $45.48 |
| 82962 | <1% | 79 | $29.85 | |
| 82948 | <1% | 25 | $4.04 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 41 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 43 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 31 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 30 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 30 | $0.00 |
| 99072 | 0% | 13 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAPPELLI, GINA (PRESIDENT)